Mangalam Drugs & Organics Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Mangalam Drugs & Organics Limited generated cash of $39,126,000, which is less than the previous year. Cash used in financing activities reached the amount of $52,267,000 last year. Net change in cash is therefore -$15,011,000.
Cash Flow
| 2010 | 76.89M | -57.98M | -19.45M |
|---|---|---|---|
| 2011 | 70.88M | -112.15M | 41.72M |
| 2012 | 70.51M | -62.40M | -4.76M |
| 2016 | 218.11M | -108.84M | -111.11M |
| 2018 | 245.76M | -159.54M | -88.18M |
| 2020 | 305.47M | -68.72M | -234.78M |
| 2021 | 275.49M | -312.85M | 26.98M |
| 2023 | 395.23M | -221.72M | -166.17M |
| 2024 | 39.12M | -118.27M | 52.26M |
MANGALAM.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 26.80M | 19.46M | 16.29M | 14.33M | 6.27M | 6.79M | 6.92M | 6.47M | 7.01M |
Operating activities | |||||||||
Net income | -90.71M | 22.13M | 395.19M | 62.52M | 293.47M | 240.16M | 6.33M | 24.23M | 18.23M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 74.92M | 109.88M | 91.75M | 82.17M | 65.68M | 44.13M | 37.36M | 32.73M | 29.71M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 10.46M | -428K | -136.08M | -223.52M | -83.91M | 88.93M | 0 | 0 | 0 |
Inventories | 168.87M | -203.60M | 62.55M | 86.10M | -306.95M | 99.99M | -157.14M | -94.08M | -61.59M |
Accounts payable | 0 | 425.25M | -139.14M | 241.79M | 168.49M | -310.04M | 0 | 0 | 0 |
Cash generated by operating activities | 39.12M | 395.23M | 275.49M | 305.47M | 245.76M | 218.11M | 70.51M | 70.88M | 76.89M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | -424K | 0 | 0 | 0 | 0 | -51K |
Investments In Property Plant And Equipment | -118.32M | -279.13M | -314.36M | -69.32M | -159.94M | -110.93M | -62.75M | -114.64M | -60.44M |
Acquisitions Net | 0 | 57.40M | 1.50M | 424K | 115K | 1.88M | 0 | 0 | 0 |
Cash generated by investing activities | -118.27M | -221.72M | -312.85M | -68.72M | -159.54M | -108.84M | -62.40M | -112.15M | -57.98M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 78M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -7.87M | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 124.86M | -38.65M | -134.42M | -123.11M | 37.27M | -181.01M | 0 | 0 | 0 |
Cash used in financing activities | 52.26M | -166.17M | 26.98M | -234.78M | -88.18M | -111.11M | -4.76M | 41.72M | -19.45M |
Net Change In Cash | -15.01M | 7.33M | -10.37M | 1.95M | -1.97M | -1.84M | 3.34M | 451K | -546K |
Cash at end of period | 11.79M | 26.80M | 5.91M | 16.29M | 4.30M | 4.95M | 10.26M | 6.92M | 6.47M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |